組織因子の活性と血液の血栓形成性におけるリスク因子の作用
Antonia Sambola1, Julio Osende, James Hathcock
1Cardiovascular Biology Research Laboratory, Mount Sinai School of Medicine, New York, NY 10029, USA.
Circulation
|February 26, 2003
まとめ
循環組織因子 (TF) の活性の増加は,糖尿病,喫煙,高脂血症における血栓性合併症に寄与する. これらの心血管リスク要因の管理は,TFレベルと関連する血栓形成のリスクを減らすことができます.
科学分野:
- 心血管科学 心血管科学
- 血液学 ヘマトロジ
- メタボリック疾患の研究
背景:
- 動脈栓塞性疾患は,循環組織因子 (TF) の上昇と関連しています.
- 糖尿病,高脂血症,喫煙などの心血管疾患のリスク要因は,血栓性合併症の増加と相関しています.
- この研究では,増加したTF活性が,2型糖尿病,喫煙者,高脂血症の被験者における高血栓性 (BT) を媒介するかどうかを調査しています.
研究 の 目的:
- 2型糖尿病患者における血中血栓形成性 (BT) に循環組織因子 (TF) 活性が果たす役割を決定する.
- 喫煙と高脂血症が循環中のTFレベルとBTに与える影響を調査する.
- TF活動による心血管リスク因子と血栓性合併症の関係を探求する.
主な方法:
- 免疫キャプチャ,リリピデーション,XA因子 (FXa) 生成による定量化された循環TF.
- バディモン perfusion 室での血栓形成を使用して血液の血栓性 (BT) を評価しました.
- 2型糖尿病 (n=36),喫煙者 (n=10) および高脂血症患者 (n=10) を研究した.
主要な成果:
- 糖尿病患者の血糖コントロールの改善により,循環中のTFとBTが減少した.
- 2本のタバコを吸うと,TFレベルが急激に上昇した.
- 超脂血症の被験者は,健康なボランティアと比較して,循環中のTFレベルが高かった.
結論:
- 循環中のTFの上昇は,糖尿病,喫煙,高脂血症の患者における血栓性リスクの増加の根本的なメカニズムである可能性があります.
- これらの発見は,世界的な心血管リスクの評価と管理の重要性を強調しています.
- TF活動をターゲットにすることは,血栓性合併症を減らすための治療戦略である可能性があります.
関連する概念動画
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.